{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["35(11)"],"submitter":["Miller CR"],"funding":["NCI NIH HHS"],"journal":["Leukemia"],"pagination":["3287-3290"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8490482"],"repository":["biostudies-literature"],"pubmed_title":["Significance of chromosome 2p gain in ibrutinib-treated chronic lymphocytic leukemia patients."],"pmcid":["PMC8490482"],"funding_grant_id":["P30 CA016058","R01 CA240493"],"pubmed_authors":["Maddocks KJ","Miller CR","Lapalombella R","Jaglowski SM","Bhat S","Hertlein EK","Labanowska J","Woyach JA","Heerema NA","Abruzzo LV","Ruppert AS","Huang Y","Grever M","Kittai AS","Byrd JC","Rogers KA"],"additional_accession":[]},"is_claimable":false,"name":"Significance of chromosome 2p gain in ibrutinib-treated chronic lymphocytic leukemia patients.","description":null,"dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Nov","modification":"2025-04-04T22:33:47.893Z","creation":"2025-02-19T03:24:05.618Z"},"accession":"S-EPMC8490482","cross_references":{"pubmed":["33820961"],"doi":["10.1038/s41375-021-01237-x"]}}